Oct
11

Now That They Have Found A Cheap, Safe Drug That Kills Most Cancers, Isn’t It A Shame?

By Pharma Tech

that pharmaceutical companies are unlikely to pay for the drug testing required because they can’t make money on unpatented medicines. The drug, dichloroacetate (DCA), has already been used for years to treat rare metabolic disorders, is known to be relatively safe, it also has no patent, so anyone could manufacturer it for a fraction of the cost of newly developed drugs. In tests it has killed lung, breast and brain cancer cells, but not healthy cells. All we now need is human trials, yet pharmaceutical companies are saying they will not help.
Shouldn’t we try to get our governments involved? Shouldn’t we be complaining to the Drug companies? Shouldn’t we be complaining to everyone?

Share and Enjoy:
  • Print this article!
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
Categories : Trials

6 Comments

1

DCA I have now!>>>>>>>>>>I have researched this molecule DCA. I BOUGHT some and will use it. 50 g costs $172. I will not wait for U Alberta to start a trial. Since it is cheap and don’t need FDA approval, any doctor or researcher csn get it and start using it. I will see how it works. Need to monitor pH and take thiamine to protect the liver. Powder mix in water.

2

I believe it you can get this medication and you have a family member who has cancer, I am sure they will try it out. Let me know if this happens

3

Sorry, you got the wrong information, dichloroacetate (DCA) is not safe it has alot of side effect. esp nerve symptoms.

4

Politicians decide by the money that is put in their pockets.
The drug companies have a lot of money, and they put it in the pockets of various politicians.
This drug will never reach anyone who needs it.
Sorry to tell you that, but it is the truth.

5

what are the side effeact. Be fore you tell people there good

6

ยังไม่มี ๑๐๐ % แต่อย่างใด มีแต่ข่าว ที่นั้นที่นี่

Leave a Comment

CommentLuv Enabled

This site uses KeywordLuv. Enter YourName@YourKeywords in the Name field to take advantage.